MondegarAI
← Tracker

Institutional

Rhenman & Partners Asset Management AB

CIK 0001599882
$810.5M
Reported AUM
86
Positions
Q1 2026
Period
2026-05-14
Filed

The Brief · Rhenman & Partners Asset Management AB · Q1 2026

AI · grounded in 13F

Rhenman & Partners Asset Management AB closed its position in Vera Therapeutics Inc VERA, reducing its exposure by $21.3M. The fund established new positions in Stryker Corporation SYK for $15.7M, Veeva Sys Inc VEEV for $15M, and Abbott Laboratories ABT for $11.5M. Additionally, the manager trimmed holdings in Cooper Cos Inc COO and Danaher Corporation DHR, reducing share counts by 84.7% and 81.8% respectively.

Portfolio · Q1 2026

BSXREGNLLYINSMCVSGILDTMOBIIBVRTXALHCISRGCOROther$517.7MRA

Top holdings

QoQ vs Q4 2025

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1BSXBOSTON SCIENTIFIC CORP$48.55-0.61%-52.44%6.47%$39.2M4.84%+193,793+44.9%
2REGNREGENERON PHARMACEUTICALS$635.451.07%29.54%11.50%$37.2M4.59%13,300−21.7%
3LLYLILLY ELI & CO$1131.420.55%48.00%387.10%$31.0M3.83%8,505−20.1%
4INSMINSMED INC$94.22-10.20%27.98%283.01%$26.1M3.22%+46,175+40.7%
5CVSCVS HEALTH CORP$95.931.17%56.40%37.47%$24.2M2.98%+1,000+0.3%
6GILDGILEAD SCIENCES INC$129.16-0.02%17.90%125.52%$23.4M2.88%+41,600+33.0%
7TMOTHERMO FISHER SCIENTIFIC INC$472.80-1.91%18.07%-11.30%$20.3M2.51%+7,700+22.9%
8BIIBBIOGEN INC$195.34-0.57%46.73%-40.21%$20.0M2.47%+16,750+18.1%
9VRTXVERTEX PHARMACEUTICALS INC$446.831.15%-0.81%121.66%$19.4M2.40%+9,230+26.9%
10ALHCALIGNMENT HEALTHCARE INC$15.371.99%0.99%-26.21%$18.6M2.29%+44,000+4.4%
11ISRGINTUITIVE SURGICAL INC$422.060.77%-24.24%27.71%$17.0M2.10%11,154−23.2%
12CORCENCORA INC$275.041.75%-4.09%142.19%$16.5M2.03%11,000−17.4%
13SYKSTRYKER CORPORATION$305.661.48%-19.61%18.51%$15.7M1.94%+47,800NEW
14ABBVABBVIE INC$227.231.02%23.60%135.68%$15.6M1.92%39,000−35.3%
15VEEVVEEVA SYS INC$172.61-3.35%-39.51%-48.12%$15.0M1.85%+85,300NEW
16MCKMCKESSON CORP$775.662.47%9.36%290.98%$14.6M1.80%8,750−34.2%
17JAZZJAZZ PHARMACEUTICALS PLC$238.57-0.62%114.68%40.73%$14.3M1.77%+1,860+2.5%
18GHGUARDANT HEALTH INC$125.61-5.60%161.36%14.40%$13.4M1.65%+65,000+81.3%
19NBIXNEUROCRINE BIOSCIENCES INC$163.88-2.07%30.70%75.82%$13.3M1.64%24,650−19.6%
20EWEDWARDS LIFESCIENCES CORP$85.96-1.70%10.89%-23.43%$13.1M1.61%30,500−15.8%
21MDGLMADRIGAL PHARMACEUTICALS INC$486.98-1.19%75.03%457.70%$12.6M1.55%+4,500+23.0%
22UNHUNITED HEALTH GROUP INC$399.470.76%35.46%5.19%$12.3M1.52%9,400−17.1%
23PRCTPROCEPT BIOROBOTICS CORP$27.833.07%-55.76%-34.87%$11.9M1.47%136,000−22.3%
24BMRNBIOMARIN PHARMACEUTICAL INC$56.770.53%0.21%-26.01%$11.7M1.44%8,000−3.7%
25ABTABBOTT LABORATORIES$91.070.32%-30.43%-17.31%$11.5M1.42%+112,000NEW
26ALNYALNYLAM PHARMACEUTICALS INC$303.05-0.19%0.74%69.36%$11.4M1.41%11,210−24.5%
27RPRXROYALTY PHARMA PLC$55.871.54%68.94%64.45%$11.2M1.38%+26,500+12.8%
28AXSMAXSOME THERAPEUTICS INC$232.320.36%107.60%378.12%$10.8M1.33%51,000−44.4%
29NTRANATERA INC$215.31-3.06%31.48%88.01%$10.3M1.27%+11,100+27.4%
30THCTENET HEALTHCARE CORP$162.060.43%-5.48%125.58%$10.2M1.26%22,504−29.4%
31ADPTADAPTIVE BIOTECHNOLOGIES COR$16.90-6.53%$10.0M1.23%+115,000+19.0%
32LIVNLIVANOVA PLC$72.36-1.84%$9.9M1.22%35,000−18.4%
33ELVELEVANCE HEALTH INC$415.531.49%$9.5M1.17%+17,300+115.3%
34ARWRARROWHEAD PHARMACEUTICALS IN$73.09-2.75%$9.1M1.12%HELD
35GKOSGLAUKOS CORP$125.002.72%$9.0M1.12%126,000−60.0%
36IQVIQVIA HLDGS INC$183.45-1.84%$9.0M1.12%+26,500+100.0%
37SNDXSYNDAX PHARMACEUTICALS INC$17.34-3.77%$8.9M1.09%107,750−22.1%
38MIRMMIRUM PHARMACEUTICALS INC$93.481.07%$8.6M1.06%13,650−12.8%
39IDYAIDEAYA Biosciences Inc$28.29-3.18%$8.5M1.05%+5,500+2.2%
40PNTGPENNANT GROUP INC$31.715.28%$8.4M1.04%81,947−22.9%
41NUVLNUVALENT INC$90.95-3.27%$8.3M1.03%82,150−50.3%
42WAYWAYSTAR HLDG CORP$20.00-1.09%$8.3M1.02%+342,566NEW
43AVRANTERIS TECHNOLOGIES GLOBAL$9.64-0.10%$8.0M0.99%+200,000+16.1%
44MDTMEDTRONIC PLC$81.67-0.32%$7.8M0.96%206,000−69.6%
45OSCROSCAR HEALTH INC$24.513.86%$7.6M0.93%+400,000+153.8%
46IOVAIOVANCE BIOTHERAPEUTICS INC$4.23-3.42%$7.2M0.89%+460,000+28.8%
47MLYSMINERALYS THERAPEUTICS INC$23.69-5.43%$7.1M0.88%+120,500+84.5%
48IONSIONIS PHARMACEUTICALS INC$74.48-0.87%$7.0M0.86%65,600−41.4%
49DNTHDIANTHUS THERAPEUTICS INC$80.51-4.30%$6.9M0.85%17,000−17.2%
50BBIOBRIDGEBIO PHARMA INC$67.610.42%$6.7M0.83%+9,000+11.0%
51APGEAPOGEE THERAPEUTICS INC$86.92-4.38%$6.3M0.78%+75,000NEW
52GPCRSTRUCTURE THERAPEUTICS INC$37.58-3.79%$6.2M0.76%19,500−13.2%
53CAHCARDINAL HEALTH INC$205.711.97%$5.7M0.70%+27,000NEW
54EHCENCOMPASS HEALTH CORP$104.014.18%$5.4M0.67%90,000−61.5%
55AMGNAMGEN INC$349.581.15%$5.3M0.66%20,800−57.8%
56VKTXVIKING THERAPEUTICS INC$28.45-4.47%$5.2M0.64%+77,000+92.8%
57NRIXNURIX THERAPEUTICS INC$14.64-4.19%$4.9M0.60%224,000−41.7%
58ALKSALKERMES PLC$42.80-1.34%$4.7M0.58%HELD
59CRLCHARLES RIV LABS INTL INC$181.34-2.40%$4.5M0.55%+4,000+18.2%
60MLTXMOONLAKE IMMUNOTHERAPEUTICS$17.90-4.38%$4.5M0.55%124,500−34.2%
61KRYSKRYSTAL BIOTECH INC$301.00-2.21%$4.3M0.53%8,325−33.3%
62DOCSDOXIMITY INC$20.59-0.53%$4.3M0.53%188,942−50.7%
63NKTRNEKTAR THERAPEUTICS$57.32-3.36%$4.2M0.52%+59,000NEW
64DNLIDENALI THERAPEUTICS INC$19.52-3.08%$3.8M0.47%+99,000+99.0%
65STVNSTEVANATO GROUP S P A$18.46-0.27%$3.8M0.47%+127,651+86.8%
66RLAYRELAY THERAPEUTICS INC$13.52-7.02%$3.6M0.44%100,000−21.7%
67COOCOOPER COS INC$67.348.58%$3.6M0.44%277,500−84.7%
68SIONSIONNA THERAPEUTICS INC$35.37-6.38%$3.5M0.43%+87,500NEW
69ASNDUSDASCENDIS PHARMA A/S$3.4M0.42%HELD
70DHRDANAHER CORPORATION$184.30-1.25%$3.4M0.42%81,000−81.8%
71PODDINSULET CORP$153.224.65%$2.9M0.36%47,000−77.0%
72AAGILENT TECHNOLOGIES INC$135.44-2.12%$2.8M0.35%+5,000+25.0%
73STOKSTOKE THERAPEUTICS INC$30.01-0.37%$2.7M0.33%133,000−61.6%
74ESPRESPERION THERAPEUTICS INC NE$3.130.00%$2.7M0.33%+985,000NEW
75IMCRIMMUNOCORE HLDGS PLC$28.29-1.63%$2.6M0.32%67,554−44.1%
76OCULOCULAR THERAPEUTIX INC$8.25-6.25%$2.6M0.32%+40,000+15.1%
77STESTERIS PLC$212.350.05%$2.5M0.31%+5,500+91.7%
78VCELVERICEL CORP$36.301.71%$2.3M0.28%47,000−40.2%
79KURAKURA ONCOLOGY IN$8.74-0.34%$2.2M0.27%600,500−68.9%
80CITHE CIGNA GROUP$289.483.14%$2.1M0.26%30,650−79.3%
81BTSGBRIGHTSPRING HEALTH SVCS INC$57.400.00%$2.1M0.26%148,000−74.7%
82XENEXENON PHARMACEUTICALS INC$51.73-2.38%$1.6M0.20%111,000−79.9%
83ALGNALIGN TECHNOLOGY INC$167.74-0.33%$1.3M0.16%91,500−92.4%
84NVCRNOVOCURE LTD$17.16-4.61%$763K0.09%+70,000NEW
85ATECALPHATEC HLDGS INC$8.001.01%$762K0.09%+50,000+250.0%
86CMPXCOMPASS THERAPEUTICS INC$2.04-4.23%$609K0.08%+115,113NEW
87VERAVERA THERAPEUTICS INC$32.29-3.27%420,000EXITED
88PENPENUMBRA INC$320.53-0.03%31,500EXITED
89APLSUSDAPELLIS PHARMACEUTICALS INC374,450EXITED
90ACLXGBXARCELLX INC133,500EXITED
91BRKRBRUKER CORP$56.39-5.97%147,315EXITED
92RYTMRHYTHM PHARMACEUTICALS INC$86.40-1.38%35,000EXITED
93RDNTRADNET INC$54.342.90%47,000EXITED
94INSPINSPIRE MED SYS INC$41.19-2.37%35,800EXITED
95JANXJANUX THERAPEUTICS INC$13.36-2.91%225,377EXITED
96PRVAPRIVIA HEALTH GROUP INC$21.631.22%125,000EXITED
97CYTKCYTOKINETICS INC$71.48-1.12%44,375EXITED
98XNCRXENCOR INC$11.77-2.00%165,750EXITED
99CNTACENTESSA PHARMACEUTICALS PLC$39.62-0.45%100,000EXITED
100TGTXTG THERAPEUTICS INC$40.16-0.99%73,250EXITED
101BNTXBIONTECH SE20,870EXITED
102WSTWEST PHARMACEUTICAL SVSC INC7,000EXITED
103CNCCENTENE CORP DEL46,231EXITED
104QUREUNIQURE NV79,375EXITED
105IRTCIRHYTHM TECHNOLOGIES INC7,000EXITED

Source: SEC EDGAR · accession 0001213900-26-056196. 13F discloses long positions only — shorts, foreign equities, and options are excluded.